The Procter & Gamble Company (NYSE:PG) Shares Bought by JB Capital LLC

JB Capital LLC grew its position in The Procter & Gamble Company (NYSE:PGFree Report) by 2.0% during the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 9,194 shares of the company’s stock after acquiring an additional 183 shares during the period. JB Capital LLC’s holdings in Procter & Gamble were worth $1,516,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also made changes to their positions in the company. Pathway Financial Advisors LLC raised its position in Procter & Gamble by 5.8% in the second quarter. Pathway Financial Advisors LLC now owns 3,866 shares of the company’s stock worth $638,000 after acquiring an additional 212 shares in the last quarter. Bay Colony Advisory Group Inc d b a Bay Colony Advisors increased its holdings in shares of Procter & Gamble by 1.0% in the 2nd quarter. Bay Colony Advisory Group Inc d b a Bay Colony Advisors now owns 16,603 shares of the company’s stock valued at $2,738,000 after purchasing an additional 165 shares in the last quarter. My Legacy Advisors LLC acquired a new stake in shares of Procter & Gamble in the second quarter valued at about $1,074,000. Unique Wealth Strategies LLC acquired a new position in Procter & Gamble during the second quarter worth about $172,000. Finally, DT Investment Partners LLC increased its holdings in Procter & Gamble by 1.6% in the second quarter. DT Investment Partners LLC now owns 22,710 shares of the company’s stock valued at $3,745,000 after buying an additional 366 shares in the last quarter. 65.77% of the stock is currently owned by institutional investors and hedge funds.

Procter & Gamble Trading Down 0.6 %

Shares of PG stock traded down $0.98 during mid-day trading on Friday, reaching $169.17. The company’s stock had a trading volume of 3,998,785 shares, compared to its average volume of 6,596,086. The company’s 50 day simple moving average is $167.25 and its 200-day simple moving average is $163.54. The company has a quick ratio of 0.53, a current ratio of 0.73 and a debt-to-equity ratio of 0.51. The Procter & Gamble Company has a 12-month low of $141.45 and a 12-month high of $171.89. The firm has a market capitalization of $399.26 billion, a PE ratio of 27.53, a price-to-earnings-growth ratio of 3.64 and a beta of 0.41.

Procter & Gamble (NYSE:PGGet Free Report) last issued its quarterly earnings data on Tuesday, July 30th. The company reported $1.40 EPS for the quarter, topping analysts’ consensus estimates of $1.37 by $0.03. Procter & Gamble had a return on equity of 33.46% and a net margin of 17.71%. The company had revenue of $20.53 billion for the quarter, compared to analysts’ expectations of $20.69 billion. During the same quarter in the previous year, the firm posted $1.37 earnings per share. The firm’s quarterly revenue was down .1% on a year-over-year basis. On average, research analysts predict that The Procter & Gamble Company will post 6.97 EPS for the current fiscal year.

Procter & Gamble Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Thursday, August 15th. Stockholders of record on Friday, July 19th were given a dividend of $1.0065 per share. This represents a $4.03 dividend on an annualized basis and a dividend yield of 2.38%. The ex-dividend date was Friday, July 19th. Procter & Gamble’s payout ratio is 65.85%.

Wall Street Analyst Weigh In

A number of equities research analysts recently weighed in on the company. Argus upped their price target on Procter & Gamble from $180.00 to $185.00 and gave the stock a “buy” rating in a report on Thursday, April 25th. Evercore ISI lifted their price target on Procter & Gamble from $177.00 to $183.00 and gave the stock an “outperform” rating in a research note on Thursday, July 18th. TD Cowen began coverage on shares of Procter & Gamble in a research note on Tuesday, July 23rd. They issued a “buy” rating and a $189.00 price objective on the stock. BNP Paribas started coverage on shares of Procter & Gamble in a research report on Monday, June 24th. They set an “outperform” rating and a $187.00 target price for the company. Finally, Dbs Bank cut shares of Procter & Gamble from a “strong-buy” rating to a “hold” rating in a research note on Thursday, August 1st. Nine investment analysts have rated the stock with a hold rating and thirteen have given a buy rating to the stock. According to MarketBeat.com, Procter & Gamble has an average rating of “Moderate Buy” and an average target price of $173.95.

Check Out Our Latest Stock Analysis on PG

Insider Activity at Procter & Gamble

In other Procter & Gamble news, insider Balaji Purushothaman sold 8,842 shares of the company’s stock in a transaction that occurred on Thursday, August 1st. The stock was sold at an average price of $164.90, for a total transaction of $1,458,045.80. Following the sale, the insider now owns 11,537 shares in the company, valued at $1,902,451.30. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. In related news, CEO Jon R. Moeller sold 72,174 shares of the business’s stock in a transaction dated Friday, August 9th. The shares were sold at an average price of $171.01, for a total transaction of $12,342,475.74. Following the completion of the sale, the chief executive officer now owns 263,158 shares of the company’s stock, valued at approximately $45,002,649.58. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, insider Balaji Purushothaman sold 8,842 shares of the firm’s stock in a transaction dated Thursday, August 1st. The stock was sold at an average price of $164.90, for a total transaction of $1,458,045.80. Following the completion of the transaction, the insider now directly owns 11,537 shares in the company, valued at approximately $1,902,451.30. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 223,259 shares of company stock valued at $37,948,393. Insiders own 0.17% of the company’s stock.

Procter & Gamble Company Profile

(Free Report)

The Procter & Gamble Company provides branded consumer packaged goods worldwide. It operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, and SK-II brands.

Further Reading

Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Procter & Gamble Company (NYSE:PGFree Report).

Institutional Ownership by Quarter for Procter & Gamble (NYSE:PG)

Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.